Adjuvant and immunostimulatory effects of beta-glucan administration in combination with lipopolysaccharide enhances survival and some immune parameters in carp challenged with Aeromonas hydrophila.
Combined effects of beta-glucan and lipopolysaccharide (LPS) on survival and immune response were studied in Cyprinus carpio that were challenged with the pathogen Aeromonas hydrophila. beta-Glucan from Saccharomyces cervisiae and LPS from a virulent strain of A. hydrophila were used in this study. Different concentrations of beta-glucan+LPS mixture were administered on days 1, 7, and 14 through different routes (intraperitoneal injection, bathing, and oral administration). Control and test fish were challenged by intraperitoneal injection of LD50 concentration of A. hydrophila on day 16 and subsequently, mortality and relative percent survival (RPS) were recorded. Intraperitoneal injection elicited 100% RPS even at the lowest concentration (100 microg beta-glucan+10 microg LPS); whereas, oral administration improved RPS rate of carps at higher concentration (1% beta-glucan+0.25% LPS). Bathing did not improve the RPS. Test animals injected with even the minimum dose of the immunomodulators (100 microg beta-glucan+10 microg LPS/fish) had a significant increase in total blood leukocyte counts and an increase in the proportion of neutrophils and monocytes. Superoxide anion production by macrophages was also elevated, which presumably aided the efficient killing of bacterial pathogen. Lower concentration of beta-glucan+LPS had an adjuvant effect on antibody production as pretreatment by injection of 100 microg beta-glucan+10 microg LPS/fish resulted in higher antibody titer against A. hydrophila following vaccination. RT-PCR analyses showed that the expression of interleukin-1beta mRNA did not increase in test fish when compared with the control. Classical and alternative complement pathways were not affected by either the dose or the route of administration of the compounds. It may be concluded that intraperitoneal injection and oral administration, and not the bathing, of beta-glucan+LPS mixture in carp could enhance resistance to challenge by A. hydrophila through changes in several non-specific and specific immune responses.
Selvaraj
V
V
Spic Research and Development, Spic Limited, Tuticorin 628005, Tamil Nadu, India.
Sampath
K
K
Sekar
Vaithilingam
V
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D016980:Aeromonas hydrophila / Q000276:immunology*; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D017756:Aquaculture / Q000379:methods; D002347:Carps / Q000276:immunology*; D003170:Complement Pathway, Alternative / Q000187:drug effects / Q000276:immunology; D003171:Complement Pathway, Classical / Q000187:drug effects / Q000276:immunology; D005393:Fish Diseases / Q000276:immunology* / Q000382:microbiology*; D016905:Gram-Negative Bacterial Infections / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D053583:Interleukin-1beta / Q000235:genetics / Q000276:immunology; D007958:Leukocyte Count / Q000662:veterinary; D008070:Lipopolysaccharides / Q000494:pharmacology*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000662:veterinary; D013481:Superoxides / Q000276:immunology; D047071:beta-Glucans / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial; D053583:Interleukin-1beta; D008070:Lipopolysaccharides; D047071:beta-Glucans; D013481:Superoxides